Rosewell Park Cancer Institute is a clinical research site located in Buffalo, New York, United States 14263.
Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.
Rosewell Park Cancer Institute has participated in 6 clinical trials with 3 currently active.
Therapeutic areas: Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes.
Sponsors: Taiho Oncology, Inc., Eisai Inc., Center for International Blood and Marrow Transplant Research.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New York · View every site in Buffalo
Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rosewell Park Cancer Institute has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rosewell Park Cancer Institute has 6 clinical trials on record, with 3 currently active. Their work covers Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes.
Rosewell Park Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.